North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 15 of 15
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:42:15
(DavidS )
UPD
FurtherInformation Changed from
Approved for use in previously treated anaplastic lymphoma kinase positive non-small-cell-lung cancer in line with NICE and NHS England Commissioning Policy.
Approved for untreated ALK-po
20/11/2023 12:42:15
(DavidS )
UPD
Ceritinib updated formatting
20/11/2023 12:42:15
(DavidS )
UPD
Ceritinib changed to protein kinase inhibitor
09/05/2018 11:23:25
(LoweryM )
UPD
Ceritinib changed to protein kinase inhibitor
09/05/2018 11:23:17
(LoweryM )
UPD
Published from Draft Mode
09/05/2018 11:05:09
(LoweryM )
UPD
Ceritinib updated
09/05/2018 11:02:02
(LoweryM )
UPD
Ceritinib updated
09/05/2018 11:01:53
(LoweryM )
LDL
Link Added : NICE TA500: Ceritinib for untreated ALK-positive non-small-cell lung cancer : https://www.nice.org.uk/guidance/ta500
27/04/2018 12:47:05
(DavidS )
UPD
Ceritinib NICE TA500 approved at APC (April 2018)
27/04/2018 12:46:36
(DavidS )
UPD
Ceritinib b
01/02/2017 14:36:18
(DavidS )
UPD
Ceritinib b
23/01/2017 15:03:56
(WhitehallJ )
UPD
Ceritinib 150mg capsules b
23/01/2017 14:19:31
(WhitehallJ )
UPD
Ceritinib 150mg capsules b
23/01/2017 14:19:30
(WhitehallJ )
UPD
Ceritinib b
23/01/2017 14:18:58
(WhitehallJ )